These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2841022)

  • 21. Etoposide in the management of non-small cell lung cancer.
    Ruckdeschel JC
    Cancer; 1991 Jan; 67(1 Suppl):250-3. PubMed ID: 1845848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
    Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
    Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer.
    Thongprasert S; Permsuwan U; Ruengorn C; Charoentum C; Chewaskulyong B
    Asia Pac J Clin Oncol; 2011 Dec; 7(4):369-75. PubMed ID: 22151987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Le Péchoux C; Arriagada R; Le Chevalier T
    Cancer; 1995 Aug; 76(3):530-1. PubMed ID: 8625139
    [No Abstract]   [Full Text] [Related]  

  • 26. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
    Makimoto T; Tsuchiya S; Nakano H; Watanabe S; Minato K; Takise A; Ezawa K; Fueki N; Naruse I; Nomoto T; Takei Y; Ishihara S; Mori M; Saitoh R
    Am J Clin Oncol; 1997 Feb; 20(1):51-4. PubMed ID: 9020288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of 2 doses of cisplatin combined with etoposide in the treatment of non-small cell carcinoma of the lung].
    Farris A; Cadau ML; Ortu R; Contu A; Piga M; Sarobba MG; Schena GP; Ginesu F
    G Ital Chemioter; 1986; 33(2-3):157-60. PubMed ID: 2824271
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
    Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
    Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
    J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin or Carboplatin for advanced non-small-cell lung cancer?
    Sun X; Zheng Y
    J Thorac Oncol; 2014 Sep; 9(9):e70. PubMed ID: 25122440
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer.
    Tueni E; Sculier JP; Klastersky J
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):963-7. PubMed ID: 3044803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line chemotherapy treatment of advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
    Tiseo M; Ardizzoni A; Boni L
    J Thorac Oncol; 2014 Nov; 9(11):e82. PubMed ID: 25436810
    [No Abstract]   [Full Text] [Related]  

  • 36. A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer.
    Krook JE; Jett JR; Little C
    Am J Clin Oncol; 1989 Apr; 12(2):114-7. PubMed ID: 2539716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Paccagnella A; Favaretto A; Brandes A; Ghiotto C; Fornasiero A; Volpi A; Pappagallo G; Festi G; Cipriani A; Vinante O
    Cancer; 1990 Jun; 65(12):2631-4. PubMed ID: 2160312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].
    Arraztoa J; Orlandi L; Rodríguez R; Vogel C; Ramírez G
    Rev Med Chil; 1987 Jan; 115(1):31-6. PubMed ID: 3039639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.